Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

October 31, 2024

Conditions
Acute Kidney Injury
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine solution will be prepared by diluting one ampoule of dexmedetomidine (200µg/2ml) with 48 ml of saline solution to obtain a dexmedetomidine solution of 4µg/ml. Patients from the experimental group will receive a continuous infusion of dexmedetomidine at a dose of 0.5 µg/kg/h, until the end of the operation.

Trial Locations (1)

21000

RECRUITING

University of Novi Sad, Faculty of Medicine, Novi Sad

All Listed Sponsors
lead

University of Novi Sad

OTHER